Compliance to continuous positive airway pressure therapy in a group of Portuguese patients with obstructive sleep apnea syndrome

Sleep and Breathing

Volumn 16, Issue 2, 2012, Pages 555-562

  Alves, Claudia ^a   Caminha, José Manuel Pinto Chaves ^a   Da Silva, Antonio Martins ^a,b   Mendonça, Denisa ^b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

CPAP compliance; CPAP treatment; Obstructive sleep apnea hypopnea syndrome

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP APNEA SYNDROME; TREATMENT DURATION;

ADULT; AMBULATORY CARE FACILITIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-CULTURAL COMPARISON; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PORTUGAL; RETROSPECTIVE STUDIES; SIGNAL PROCESSING, COMPUTER-ASSISTED; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AS TOPIC; UTILIZATION REVIEW;

EID: 84861481292     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-011-0542-9     Document Type: Article

References (61)

1. Joo EY, Tae WS, Han SJ, Cho JW, Hong SB (2007) Reduced cerebral blood flow during wakefulness in obstructive sleep apnea-hypopnea syndrome. Sleep 30(11):1515-1520
2. Engleman HM, KingShot RN, Martin SE, Douglas NJ (2000) Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep 23(4):S102-S108
3. Giradin JL, Zizi F, Luther C, Brown CD, McFarlane SI (2008) Obstructive sleep apnea and cardiovascular disease: role of metabolic syndrome and its components. J Clin Sleep Med 4(3):261-272 (Pubitemid 352039439)
4. Arias MA, Alonso-Fernández A, García-Río F (2006) Obstructive sleep apnea as an independent risk factor for stroke and mortality. Stroke 37:1150 (Pubitemid 43731845)
5. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. New Engl J Med 353(19):2034-2041 (Pubitemid 41609096)
6. Connor J, Whitlock G, Norton R, Jackson R (2001) The role of driver sleepiness in car crashes: a systemic review of epidemiological studies. Accident Anal Prev 33:31-41
7. Lindberg E, Gislason T (2000) Clinical review article: epidemiology of sleep-related obstructive breathing. Sleep Med Rev 4(5):411-433
8. Sánchez AI, Martínez P, Miró E, Bardwell WA, Buela-Casal G (2009) CPAP and behavioral therapies in patients with obstructive sleep apnea: effects on daytime sleepiness, mood, and cognitive function. Sleep Med Rev 13:223-233
9. Kajast S, Brander PE, Telakivi T, Partinem M, Mustajoki P (2004) A cognitive-behavioral weight reduction program in the treatment of sleep obstructive sleep apnea with or without initial nasal CPAP: a randomized study. Sleep Med 5:125-131 (Pubitemid 38351823)
10. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J (2000) Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284:3015-3021 (Pubitemid 32014738)
11. Penzel T, Möler M, Becker HF, Knaack L, Peter JH (2001) Effect of sleep position and sleep stage on the collapsibility of upper airways in patients with sleep apnea. Sleep 24:90-95 (Pubitemid 32096738)
12. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ (2006) Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 29(8):1036-1044 (Pubitemid 44257381)
13. Smith I, Lasserson TJ, Wright JJ (2006) Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2:CD003002. doi:10.1002/14651858.CD003002.pub2
14. Ryan CF (2005) An approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgery. Thorax 60:595-604
15. Sundaram S, Lim J, Lasserson TJ (2005) Surgery for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 4:CD001004. doi:10.1002/14651858. CD001004.pub2
16. Giles TL, Lasserson TJ, Smith B, White JJ, Cates CJ (2006) Continuous positive airway pressure for obstructive sleep apnoea in adults (review). Cochrane Database Syst Rev 1: CD001106. doi:10.1002/14651858.CD001106.pub2
17. Scottish Intercollegiate Guidelines Network (SIGN) (2003) Management of obstructive sleep apnoea/hypopnoea syndrome in adults (guideline no.73). http://www.sign.ac.uk/pdf/sign73.pdf. Accessed 3 March 2010
18. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ (1998) Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 53:341-345 (Pubitemid 28261322)
19. Engleman HM, Martin SE, Deary IJ, Douglas NJ (1994) Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea-hypopnoea syndrome. Lancet 343:572-575 (Pubitemid 24066377)
20. Engleman HM, Martin SE, Deary IJ, Douglas NJ (1997) Effect of CPAP therapy on daytime function in patients with mild sleep apnoea-hypopnoea syndrome. Thorax 52:114-119 (Pubitemid 27086736)
21. Munoz A, Mayoralas LR, Barbe F, Pericas J, Agusti AG (2000) Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J 15:676-681 (Pubitemid 30196294)
22. Montserrat JM, Montserrat F, Hernandez L, Farré L, Vilagut G, Navajas D et al (2001) Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Resp Crit Care Med 164:608-613 (Pubitemid 32801664)
23. Ballester E, Badia JR, Hernández L, Carrasco E, Pablo J, Fornas C, Rodriguez-Roisin R, Montserrat JM (1999) Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea-hypopnea syndrome. Am J Resp Crit Care Med 159:495-501 (Pubitemid 29084871)
24. Monasterio C, Vidal S, Duran J, Ferrer M, Carmona C, Barbé F, Mayos M, Gonzalez-Mangado N, Juncadella M, Navarro A, Barreira R, Capote F, Mayoralas LR, Peces-Barba G, Alonso J, Montserrat JM (2001) Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Resp Crit Care Med 164:939-943 (Pubitemid 32971636)
25. Engleman HM, Cheshire KE, Deary IJ, Douglas JN (1993) Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea-hypopnoea syndrome. Thorax 48:911-914 (Pubitemid 23283385)
26. McArdle N, Douglas NJ (2001) Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Resp Crit Care Med 164:1459-1463 (Pubitemid 33124027)
27. Weaver TE, Chasens ER (2007) Continuous positive airway pressure treatment for sleep apnea in older adults. Sleep Med Rev 11(2):99-111 (Pubitemid 46343798)
28. Nelesen RA, Yu H, Ziegler MG, Mills PJ, Clausen JL, Dimsdale JE (2001) Continuous positive airway pressure normalizes cardiac autonomic and hemodynamic responses to a laboratory stressor in apneic patients. Chest 119:1092-1101 (Pubitemid 32679436)
29. Rutherford R, Xie A, Malone S, Liu PP, Bradley TD, Holloway R (1991) Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 338:1480-1484
30. Krieger J, Grucker D, Sforza E, Chambrom J, Kurtz D (1991) Left ventricular ejection fraction in obstructive sleep apnea. Effects of long-term treatment with nasal continuous positive airway pressure. Chest 100:917-921
31. Krieger J, Follenius M, Sforza E, Brandenberger G, Peter JDl (1991) Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci 80:443-449
32. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan C, Peter H (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68-73 (Pubitemid 36070935)
33. Pepperell JC (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359:204-210
34. Durán-Cantolla J, Aizpuru F, Martínez-Null C, Barbé-Illa F (2009) Obstructive sleep apnea-hypopnea and systemic hypertension. Sleep Med Rev 13:323-331
35. Buechner NJ, Zidek W, Esser M, Haske M, Sanner BM (2001) Obstructive sleep apnea syndrome. Effects of therapy on dyslipidemia. Somnologie 5:97-102 (Pubitemid 32844649)
36. Comondore VR, Cheema R, Fox J, Butt A, Mancini J, Fleetham JA, Ryan CF, Chan S, Ayas NT (2008) The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung 186:209-217
37. Cuhadaroglu C, Utkusavas A, Ozturk L, Salman S, Ece T (2009) Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 187:75-81
38. Saarelainen S, Lahtela J, Kallonen E (1997) Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 6:146-147 (Pubitemid 27300274)
39. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706-712 (Pubitemid 29383639)
40. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, Ohi M (2000) Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109:562-567
41. Duchna HW, Guilleminault C, Stoohs RA, Faul JL, Moreno H, Hoffman BB, Blaschke TF (2000) Vascular reactivity in obstructive sleep apnea syndrome. Am J Resp Crit Care Med 161:187-191 (Pubitemid 30055924)
42. Bahammam A, Delaive K, Ronald J, Manfred J, Ross L, Kryger MH (1999) Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep 22(6):740-747 (Pubitemid 29445341)
43. Albarrak M, Banno M, Sabagh AA, Delaive K, Walld R, Manfreda J, Kryger MH (2005) Utilization of healthcare resources in obstructive sleep apnea syndrome: a 5-year follow-up study in men using CPAP. Sleep 28(10):1306-1311 (Pubitemid 41437892)
44. Banno K, Manfreda J, Walld R, Delaive K, Kryger MH (2006) Healthcare utilization in women with obstructive sleep apnea syndrome 2 years after diagnosis and treatment. Sleep 29(10):1307-1311 (Pubitemid 44571984)
45. AlGhanim N, Comondore VR, Fleetham J, Marra CA, Avas NT (2008) The economic impact of obstructive sleep apnea. Lung 186(1):7-12
46. Weaver TE, Ronald G (2008) Adherence to continuous positive airway pressure therapy-the challenge to effective treatment. Proc Am Thorac Soc 5:173-178 (Pubitemid 351237875)
47. Berry RB (2000) Improving CPAP compliance-man more than machine. Sleep Med 1(3):175-178
48. Weaver TE (2006) Adherence to positive airway pressure therapy. Curr Opin Pulm Med 12:409-413
49. Olsen S, Smith S, Oei TPS (2008) Adherence to continuous positive airway pressure therapy in obstructive sleep apnoea sufferers: a theoretical approach to treatment adherence and intervention. Clin Psychol Rev 28(8):1355-1371
50. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Department of Health, Education, and Welfare Public Health Service-NIH/NIND.
51. Kribbs NB, Pack AI, Kline LR (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147:887-895 (Pubitemid 23093812)
52. Sin DD, Mayers I, Man GCW, Pawluk L (2002) Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea. Chest 121:430-435 (Pubitemid 34132979)
53. Amfilochiou A, Tsara V, Kolilekas L, Gizopoulou E, Maniou C, Bouros D, Polychronopoulos V (2009) Determinants of continuous positive airway pressure compliance in a group of Greek patients with obstructive sleep apnea. Eur J Intern Med 20:645-650
54. Engleman HM, Martin SE, Douglas NJ (1994) Compliance with CPAP therapy in patients with the sleep apnoea-hypopnoea syndrome. Thorax 49:263-266 (Pubitemid 24117454)
55. Reeves-Hoche MK, Meck R, Zwillich CW (1994) Nasal CPAP: an objective evaluation of patient compliance. Am J Resp Crit Care Med 149(1):149-154 (Pubitemid 24066112)
56. Pieters T, Collard P, Aubert G, Dury M, Delguste P, Rodenstein DO (1996) Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J 9:939-944 (Pubitemid 26191638)
57. Alarcón A, León C, Maimó A, Barbé F, Augustí AG, Rodríguez-Roisin R, Granados A, Montserrat JM (1995) Compliance with nasal positive airway pressure (CPAP) treatment in sleep apneahypopnea syndrome. Arch Bronconeumol 31(2):56-61
58. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ (1999) Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Resp Crit Care Med 159:1108-1114 (Pubitemid 29202543)
59. Pelletier-Fleury N, Rakotonanahary D, Fleury B (2001) The age and other factors in the evaluation of compliance with nasal continuous positive airway pressure for obstructive sleep apnea syndrome. A Cox's proportional hazard analysis. Sleep Med 2:225-232 (Pubitemid 34846771)
60. Anttalainen U, Saaresranta T, Kalleinen N, Aittokallio J, Vahlberg T, Polo O (2007) CPAP adherence and partial upper airway obstruction during sleep. Sleep Breath 11:171-176 (Pubitemid 47307846)
61. Yetkin O, Kunter E, Gunen H (2008) CPAP compliance in patients with obstructive sleep apnea syndrome. Sleep Breath 12:365-367